Gevo (NASDAQ:GEVO) Stock Price Crosses Above 200 Day Moving Average - Here's What Happened

Gevo, Inc. (NASDAQ:GEVO - Get Free Report)'s stock price crossed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $1.38 and traded as high as $1.48. Gevo shares last traded at $1.38, with a volume of 2,550,202 shares.

Analyst Ratings Changes

A number of brokerages have weighed in on GEVO. HC Wainwright reaffirmed a "buy" rating and issued a $14.00 target price on shares of Gevo in a report on Friday, May 30th. Wall Street Zen upgraded Gevo from a "sell" rating to a "hold" rating in a research note on Friday, July 18th. Finally, UBS Group dropped their price target on Gevo from $3.25 to $1.15 and set a "neutral" rating for the company in a research note on Wednesday, April 2nd.

Gevo Price Performance

The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.71 and a current ratio of 2.04. The stock has a market cap of $318.61 million, a PE ratio of -3.69 and a beta of 2.52. The business has a 50 day moving average price of $1.34 and a two-hundred day moving average price of $1.38.

Gevo (NASDAQ:GEVO - Get Free Report) last issued its earnings results on Tuesday, May 13th. The energy company reported ($0.09) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.10) by $0.01. The business had revenue of $29.11 million for the quarter, compared to analysts' expectations of $22.19 million. Gevo had a negative net margin of 193.87% and a negative return on equity of 16.41%. Research analysts expect that Gevo, Inc. will post -0.42 earnings per share for the current fiscal year.

Insider Activity

In related news, EVP L Lynn Smull sold 60,331 shares of the company's stock in a transaction on Friday, May 30th. The shares were sold at an average price of $1.28, for a total value of $77,223.68. Following the completion of the transaction, the executive vice president directly owned 1,109,271 shares in the company, valued at approximately $1,419,866.88. The trade was a 5.16% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Andrew Shafer sold 27,538 shares of the company's stock in a transaction on Friday, May 30th. The stock was sold at an average price of $1.28, for a total transaction of $35,248.64. Following the completion of the transaction, the insider owned 284,892 shares of the company's stock, valued at $364,661.76. This trade represents a 8.81% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 469,186 shares of company stock worth $599,429. Company insiders own 6.80% of the company's stock.

Institutional Trading of Gevo

Several institutional investors have recently added to or reduced their stakes in the business. Raymond James Financial Inc. bought a new position in shares of Gevo during the fourth quarter valued at approximately $27,000. IHT Wealth Management LLC bought a new position in Gevo in the fourth quarter worth approximately $29,000. International Assets Investment Management LLC bought a new position in Gevo in the second quarter worth approximately $26,000. Commonwealth Equity Services LLC purchased a new position in shares of Gevo during the 4th quarter valued at $49,000. Finally, ExodusPoint Capital Management LP purchased a new position in shares of Gevo during the 4th quarter valued at $49,000. 35.17% of the stock is currently owned by hedge funds and other institutional investors.

Gevo Company Profile

Gevo, Inc operates as a carbon abatement company. It operates through three segments: Gevo, Agri-Energy, and Renewable Natural Gas. The company focuses on transforming renewable energy into energy-dense liquid hydrocarbons that can be used as renewable fuels. It offers renewable gasoline and diesel, isobutanol, sustainable aviation fuel, renewable natural gas, isobutylene, ethanol, and animal feed and protein.